In last trading session, Sage Therapeutics Inc (NASDAQ:SAGE) saw 1.52 million shares changing hands with its beta currently measuring 0.96. Company’s recent per share price level of $13.28 trading at -$0.66 or -4.73% at ring of the bell on the day assigns it a market valuation of $799.19M. That closing price of SAGE’s stock is at a discount of -351.73% from its 52-week high price of $59.99 and is indicating a premium of 17.77% from its 52-week low price of $10.92. Taking a look at company’s average trading volume volume of 1.06 million if we extend that period to 3-months.

Sage Therapeutics Inc (NASDAQ:SAGE) trade information

Upright in the red during last session for losing -4.73%, in the last five days SAGE remained trading in the red while hitting it’s week-highest on Thursday, 04/25/24 when the stock touched $13.28 price level, adding 11.29% to its value on the day. Sage Therapeutics Inc’s shares saw a change of -38.72% in year-to-date performance and have moved -5.14% in past 5-day. Sage Therapeutics Inc (NASDAQ:SAGE) showed a performance of -23.01% in past 30-days.

Sage Therapeutics Inc (SAGE) estimates and forecasts

Statistics highlight that Sage Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -28.64% of value to its shares in past 6 months, showing an annual growth rate of 27.07% while that of industry is 11.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.28% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 28.60% while estimates for its earnings growth in next 5 years are of 16.80%.

SAGE Dividends

Sage Therapeutics Inc is more likely to be releasing its next quarterly report on April 25 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.